Composition and capacity of Institutional Review Boards, and challenges experienced by members in ethics review processes in Addis Ababa, Ethiopia: An exploratory qualitative study
Open Access
- 5 March 2022
- journal article
- review article
- Published by Wiley in Developing World Bioethics
- Vol. 23 (1) , 50-58
Abstract
Few studies in sub‐Saharan Africa evaluate Institutional Review Boards (IRBs) capacity. The study aims to explore the composition of IRBs, training, and challenges experienced in the ethics review processes by members of research institutions and universities in Addis Ababa, Ethiopia. Our findings indicate that most IRBs members were trained on research ethics and good clinical practice. However, majority perceived the trainings as basic. IRB members faced several challenges including: investigators wanting rapid review; time pressure; investigators not following checklists; limited expertise in reviewing clinical trials, studies on genetics, and traditional medicine; lack of IRB offices for administrative work; competing tasks; limited staffing and the lack of a standardized review system. There is need for advanced training on research ethics to meet the evolving research needs. In addition, investments in IRBs are needed in terms of funding, and physical and human resources in Addis Ababa and Ethiopia in general.Keywords
This publication has 23 references indexed in Scilit:
- Evaluating institutional capacity for research ethics in Africa: a case study from BotswanaBMC Medical Ethics, 2013
- TRAINING NEEDS ASSESSMENT IN RESEARCH ETHICS EVALUATION AMONG RESEARCH ETHICS COMMITTEE MEMBERS IN THREE AFRICAN COUNTRIES: CAMEROON, MALI AND TANZANIADeveloping World Bioethics, 2010
- Identifying structures, processes, resources and needs of research ethics committees in EgyptBMC Medical Ethics, 2010
- Composition, training needs and independence of ethics review committees across Africa: are the gate-keepers rising to the emerging challenges?Journal of Medical Ethics, 2009
- Ethical and Scientific Implications of the Globalization of Clinical ResearchNew England Journal of Medicine, 2009
- Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) TrialAmerican Heart Journal, 2008
- Coronary Intervention for Persistent Occlusion after Myocardial InfarctionNew England Journal of Medicine, 2006
- The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: a case studyJournal of Medical Ethics, 2006
- Clinical Trials Seen Shifting OverseasInternational Journal of Health Services, 2004
- What Makes Clinical Research in Developing Countries Ethical? The Benchmarks of Ethical ResearchThe Journal of Infectious Diseases, 2004